FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4383531882> ?p ?o ?g. }

• W4383531882 endingPage "325762" @default.
• W4383531882 startingPage "archdischild" @default.
• W4383531882 abstract "Objective Spinal muscular atrophy (SMA) is a neuromuscular disorder that manifests with motor deterioration and respiratory complications. The paradigm of care is shifting as disease-modifying therapies including nusinersen, onasemnogene abeparvovec and risdiplam alter the disease trajectory of SMA. The objective of this study was to explore caregivers’ experiences with disease-modifying therapies for SMA. Design Qualitative study including semistructured interviews with caregivers of children with SMA who received disease-modifying therapies. Interviews were audio recorded, transcribed verbatim, coded and analysed using content analysis. Setting The Hospital for Sick Children (Toronto, Canada). Results Fifteen family caregivers of children with SMA type 1 (n=5), type 2 (n=5) and type 3 (n=5) participated. There were two emerging themes and several subthemes (in parentheses): (1) inequities in access to disease-modifying therapies (variable regulatory approvals, prohibitively expensive therapies and insufficient infrastructure) and (2) patient and family experience with disease-modifying therapies (decision making, hope, fear and uncertainty). Conclusion The caregiver experience with SMA has been transformed by the advent of disease-modifying therapies. Consistent and predictable access to disease-modifying therapies is a major concern for caregivers of children with SMA but is influenced by regulatory approvals, funding and eligibility criteria that are heterogenous across jurisdictions. Many caregivers described going to great lengths to access therapies, highlighting issues related to justice, such as equity and access. This diverse population reflects contemporary patients and families with SMA; their broad experiences may inform the healthcare delivery of other emerging orphan drugs." @default.
• W4383531882 created "2023-07-08" @default.
• W4383531882 creator A5021681120 @default.
• W4383531882 creator A5028997143 @default.
• W4383531882 creator A5030346985 @default.
• W4383531882 creator A5032280735 @default.
• W4383531882 creator A5047106873 @default.
• W4383531882 creator A5052905906 @default.
• W4383531882 creator A5054836427 @default.
• W4383531882 creator A5055721453 @default.
• W4383531882 creator A5060761997 @default.
• W4383531882 creator A5063981686 @default.
• W4383531882 creator A5079794409 @default.
• W4383531882 date "2023-07-07" @default.
• W4383531882 modified "2023-10-18" @default.
• W4383531882 title "Understanding caregiver experiences with disease-modifying therapies for spinal muscular atrophy: a qualitative study" @default.
• W4383531882 cites W1980537418 @default.
• W4383531882 cites W2048181785 @default.
• W4383531882 cites W2064071397 @default.
• W4383531882 cites W2098529946 @default.
• W4383531882 cites W2134418108 @default.
• W4383531882 cites W2138664283 @default.
• W4383531882 cites W2752787259 @default.
• W4383531882 cites W2765253110 @default.
• W4383531882 cites W2766452915 @default.
• W4383531882 cites W2768938988 @default.
• W4383531882 cites W2792714325 @default.
• W4383531882 cites W2888217156 @default.
• W4383531882 cites W2908335062 @default.
• W4383531882 cites W3037947732 @default.
• W4383531882 cites W3045690296 @default.
• W4383531882 cites W3133019004 @default.
• W4383531882 cites W3143238609 @default.
• W4383531882 cites W3155607547 @default.
• W4383531882 cites W3186720955 @default.
• W4383531882 cites W4211151467 @default.
• W4383531882 doi "https://doi.org/10.1136/archdischild-2023-325762" @default.
• W4383531882 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37419673" @default.
• W4383531882 hasPublicationYear "2023" @default.
• W4383531882 type Work @default.
• W4383531882 citedByCount "0" @default.
• W4383531882 crossrefType "journal-article" @default.
• W4383531882 hasAuthorship W4383531882A5021681120 @default.
• W4383531882 hasAuthorship W4383531882A5028997143 @default.
• W4383531882 hasAuthorship W4383531882A5030346985 @default.
• W4383531882 hasAuthorship W4383531882A5032280735 @default.
• W4383531882 hasAuthorship W4383531882A5047106873 @default.
• W4383531882 hasAuthorship W4383531882A5052905906 @default.
• W4383531882 hasAuthorship W4383531882A5054836427 @default.
• W4383531882 hasAuthorship W4383531882A5055721453 @default.
• W4383531882 hasAuthorship W4383531882A5060761997 @default.
• W4383531882 hasAuthorship W4383531882A5063981686 @default.
• W4383531882 hasAuthorship W4383531882A5079794409 @default.
• W4383531882 hasConcept C114614502 @default.
• W4383531882 hasConcept C142724271 @default.
• W4383531882 hasConcept C144024400 @default.
• W4383531882 hasConcept C160735492 @default.
• W4383531882 hasConcept C161921814 @default.
• W4383531882 hasConcept C162324750 @default.
• W4383531882 hasConcept C1862650 @default.
• W4383531882 hasConcept C190248442 @default.
• W4383531882 hasConcept C2776356578 @default.
• W4383531882 hasConcept C2778558090 @default.
• W4383531882 hasConcept C2779134260 @default.
• W4383531882 hasConcept C2908647359 @default.
• W4383531882 hasConcept C33923547 @default.
• W4383531882 hasConcept C36289849 @default.
• W4383531882 hasConcept C50522688 @default.
• W4383531882 hasConcept C512399662 @default.
• W4383531882 hasConcept C71924100 @default.
• W4383531882 hasConcept C99454951 @default.
• W4383531882 hasConceptScore W4383531882C114614502 @default.
• W4383531882 hasConceptScore W4383531882C142724271 @default.
• W4383531882 hasConceptScore W4383531882C144024400 @default.
• W4383531882 hasConceptScore W4383531882C160735492 @default.
• W4383531882 hasConceptScore W4383531882C161921814 @default.
• W4383531882 hasConceptScore W4383531882C162324750 @default.
• W4383531882 hasConceptScore W4383531882C1862650 @default.
• W4383531882 hasConceptScore W4383531882C190248442 @default.
• W4383531882 hasConceptScore W4383531882C2776356578 @default.
• W4383531882 hasConceptScore W4383531882C2778558090 @default.
• W4383531882 hasConceptScore W4383531882C2779134260 @default.
• W4383531882 hasConceptScore W4383531882C2908647359 @default.
• W4383531882 hasConceptScore W4383531882C33923547 @default.
• W4383531882 hasConceptScore W4383531882C36289849 @default.
• W4383531882 hasConceptScore W4383531882C50522688 @default.
• W4383531882 hasConceptScore W4383531882C512399662 @default.
• W4383531882 hasConceptScore W4383531882C71924100 @default.
• W4383531882 hasConceptScore W4383531882C99454951 @default.
• W4383531882 hasLocation W43835318821 @default.
• W4383531882 hasLocation W43835318822 @default.
• W4383531882 hasOpenAccess W4383531882 @default.
• W4383531882 hasPrimaryLocation W43835318821 @default.
• W4383531882 hasRelatedWork W1974226216 @default.
• W4383531882 hasRelatedWork W2883726401 @default.
• W4383531882 hasRelatedWork W2921088799 @default.
• W4383531882 hasRelatedWork W3193767101 @default.
• W4383531882 hasRelatedWork W4283272397 @default.

• next